GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Profitability Rank

Innovative Pharmaceutical Biotech (HKSE:00399) Profitability Rank : 2 (As of Sep. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Profitability Rank?

Innovative Pharmaceutical Biotech has the Profitability Rank of 2. It has had trouble to make a profit.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Innovative Pharmaceutical Biotech's Operating Margin % for the quarter that ended in Sep. 2023 was -166.68%. As of today, Innovative Pharmaceutical Biotech's Piotroski F-Score is 4.


Competitive Comparison of Innovative Pharmaceutical Biotech's Profitability Rank

For the Household & Personal Products subindustry, Innovative Pharmaceutical Biotech's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative Pharmaceutical Biotech's Profitability Rank Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Innovative Pharmaceutical Biotech's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's Profitability Rank falls into.



Innovative Pharmaceutical Biotech Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Innovative Pharmaceutical Biotech has the Profitability Rank of 2. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Innovative Pharmaceutical Biotech's Operating Margin % for the quarter that ended in Sep. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=-6.212 / 3.727
=-166.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Innovative Pharmaceutical Biotech has an F-score of 4 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Warning Sign:

Innovative Pharmaceutical Biotech Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -9.5%.

4. Consistency of the profitability

5. Predictability Rank


Innovative Pharmaceutical Biotech Profitability Rank Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Pharmaceutical Biotech (HKSE:00399) Business Description

Traded in Other Exchanges
N/A
Address
168-200 Connaught Road Central, Unit No. 2111, 21st Floor, Sheung Wan, West Tower Shun Tak Centre, Hong Kong, HKG
Innovative Pharmaceutical Biotech Ltd is focused on developing an insulin product that could be administered orally. It has two primary segments of business: the research and development of pharmaceutical products and the trading of beauty products. It generates maximum revenue from trading in the beauty products segment.
Executives
Mao Yumin 2101 Beneficial owner
Extrawell Pharmaceutical Holdings Limited
Chau Yiu Ting 2101 Beneficial owner
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner

Innovative Pharmaceutical Biotech (HKSE:00399) Headlines

No Headlines